Anne Barton Selected Research

Anne Barton Research Topics

Disease

105	Rheumatoid Arthritis 01/2024 - 05/2002
24	Arthritis (Polyarthritis) 11/2023 - 01/2004
19	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 01/2004
19	Necrosis 01/2024 - 10/2007
13	Psoriatic Arthritis 01/2024 - 01/2004
8	Inflammation (Inflammations) 11/2022 - 07/2012
6	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 03/2004
5	Rheumatic Diseases (Rheumatism) 11/2023 - 05/2015
5	Joint Diseases (Joint Disease) 01/2016 - 06/2007
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 03/2011
3	Crohn Disease (Crohn's Disease) 02/2014 - 03/2005
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2009 - 06/2005
2	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 01/2021
2	Synovitis 10/2020 - 03/2019
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2021
1	Infections 01/2019
1	Obesity 01/2018
1	Pneumonia (Pneumonitis) 12/2017
1	Spondylarthropathies 10/2017
1	Ankylosing Spondylitis 10/2017
1	Vasculitis (Vasculitides) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Disease Susceptibility (Diathesis) 04/2015
1	Genetic Risk Score 01/2015
1	Breast Neoplasms (Breast Cancer) 07/2013

Drug/Important Bio-Agent (IBA)

18	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 02/2014
17	Tumor Necrosis Factor InhibitorsIBA 12/2023 - 01/2011
14	AntibodiesIBA 01/2024 - 05/2010
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 10/2007
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2015
11	Etanercept (Enbrel)FDA Link 01/2024 - 03/2013
11	Adalimumab (Humira)FDA Link 01/2024 - 06/2014
11	HLA-DRB1 Chains (HLA DRB1)IBA 09/2023 - 12/2004
9	AutoantibodiesIBA 01/2021 - 06/2005
8	Antirheumatic Agents (DMARD)IBA 01/2024 - 11/2008
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2004
8	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 02/2008
7	Rheumatoid FactorIBA 01/2016 - 01/2004
6	C-Reactive ProteinIBA 01/2023 - 10/2012
5	EpitopesIBA 01/2018 - 06/2007
5	ametantrone (HAQ)IBA 11/2016 - 01/2010
5	cyclic citrullinated peptideIBA 01/2016 - 02/2008
4	Amino Acids FDA Link 01/2022 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2011
4	HLA-C Antigens (HLA-C)IBA 08/2019 - 11/2010
4	Peptides (Polypeptides)IBA 12/2012 - 05/2012
3	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2015
3	Genetic Markers (Genetic Marker)IBA 11/2016 - 12/2012
3	Interleukin-13IBA 08/2012 - 09/2010
2	Rituximab (Mabthera)FDA Link 11/2023 - 07/2012
2	tocilizumab (atlizumab)FDA Link 11/2023 - 01/2019
2	HLA-B Antigens (HLA-B)IBA 10/2017 - 01/2015
2	Valine (L-Valine)FDA Link 11/2016 - 04/2015
2	Immunoglobulin G (IgG)IBA 01/2016 - 03/2015
2	Infliximab (Remicade)FDA Link 03/2015 - 06/2014
2	AntigensIBA 01/2015 - 06/2007
2	Vitamin D FDA LinkGeneric 07/2014 - 05/2014
2	TNF Receptor-Associated Factor 1IBA 02/2013 - 01/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2010 - 07/2010
2	Type II Tumor Necrosis Factor ReceptorsIBA 05/2010 - 08/2005
2	CytokinesIBA 10/2007 - 03/2005
1	InterferonsIBA 10/2023
1	HLA-DQA1 antigen (HLA DQA1)IBA 09/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023
1	LipidsIBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Complement C4 (Complement Component 4)IBA 10/2022
1	Immunomodulating AgentsIBA 09/2022
1	Pharmacological BiomarkersIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 10/2019
1	Interleukin-10 (Interleukin 10)IBA 10/2019
1	amsonic acid (DAS)IBA 03/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	SteroidsIBA 01/2019
1	ChromatinIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	HLA-A31 antigenIBA 12/2017
1	Interleukin-4 (Interleukin 4)IBA 11/2017
1	Serine (L-Serine)FDA Link 10/2017
1	AsparagineIBA 10/2017
1	Certolizumab Pegol FDA Link 01/2017
1	Monoclonal AntibodiesIBA 11/2016
1	interleukin 20 (IL-20)IBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 11/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2016
1	LigandsIBA 11/2015
1	CXC ChemokinesIBA 11/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2015
1	Anti-Idiotypic AntibodiesIBA 02/2015
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2014
1	IGF-I-IGFBP-3 complex FDA Link 10/2012
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 08/2012

Therapy/Procedure

31	Therapeutics 01/2024 - 04/2009
7	Biological Therapy 11/2023 - 03/2013
4	Precision Medicine 01/2023 - 07/2015
1	Immunomodulation 01/2018
1	Drug Therapy (Chemotherapy) 01/2016